CB1 Receptor Silencing Attenuates Ketamine-Induced Hyperlocomotion Without Compromising Its Antidepressant-Like Effects
September 7th, 2022 | Posted in Cannabinoid Research | Comments Off on CB1 Receptor Silencing Attenuates Ketamine-Induced Hyperlocomotion Without Compromising Its Antidepressant-Like Effects
CB1 Receptor Silencing Attenuates Ketamine-Induced Hyperlocomotion Without Compromising Its Antidepressant-Like Effects
Cannabis and Cannabinoid Research, Ahead of Print.
Go to Source
Powered by WPeMatico
